Cambridge Investment Research Advisors
EXAS

Cambridge Investment Research Advisors’s Exact Sciences EXAS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,703
Closed -$2.81M – 3980
2025
Q4 		$2.81M Sell
27,703
-1,671
-6% -$134K 0.01% 1258
2025
Q3 		$1.61M Buy
29,374
+991
+3% +$49.5K ﹤0.01% 1676
2025
Q2 		$1.51M Buy
28,383
+3,554
+14% +$181K ﹤0.01% 1655
2025
Q1 		$1.07M Sell
24,829
-16,904
-41% -$856K ﹤0.01% 1808
2024
Q4 		$2.35M Sell
41,733
-895
-2% -$55.7K 0.01% 1249
2024
Q3 		$2.9M Sell
42,628
-351
-0.8% -$19.8K 0.01% 1098
2024
Q2 		$1.82M Buy
42,979
+14,188
+49% +$781K 0.01% 1343
2024
Q1 		$1.99M Sell
28,791
-116
-0.4% -$7.34K 0.01% 1261
2023
Q4 		$2.14M Sell
28,907
-1,691
-6% -$111K 0.01% 1157
2023
Q3 		$2.09M Sell
30,598
-2,827
-8% -$240K 0.01% 1108
2023
Q2 		$3.14M Sell
33,425
-871
-3% -$67.9K 0.01% 891
2023
Q1 		$2.33M Sell
34,296
-2,157
-6% -$139K 0.01% 1049
2022
Q4 		$1.8M Buy
36,453
+17,806
+95% +$728K 0.01% 1136
2022
Q3 		$606K Sell
18,647
-493
-3% -$20.3K ﹤0.01% 1812
2022
Q2 		$754K Sell
19,140
-16,638
-47% -$890K ﹤0.01% 1665
2022
Q1 		$2.5M Sell
35,778
-5,752
-14% -$420K 0.01% 1011
2021
Q4 		$3.23M Buy
41,530
+2,363
+6% +$209K 0.01% 877
2021
Q3 		$3.74M Buy
39,167
+1,167
+3% +$123K 0.02% 744
2021
Q2 		$4.72M Buy
+38,000
New +$4.54M 0.02% 646
2021
Q1 		– Sell
-36,483
Closed -$4.83M – 2904
2020
Q4 		$4.83M Buy
36,483
+4,812
+15% +$582K 0.03% 544
2020
Q3 		$3.23M Sell
31,671
-50
-0.2% -$4.32K 0.02% 591
2020
Q2 		$2.76M Sell
31,721
-2,141
-6% -$171K 0.02% 641
2020
Q1 		$1.96M Buy
33,862
+7,741
+30% +$628K 0.02% 674
2019
Q4 		$2.42M Sell
26,121
-5,637
-18% -$496K 0.02% 715
2019
Q3 		$2.87M Buy
31,758
+456
+1% +$52K 0.03% 617
2019
Q2 		$3.69M Buy
31,302
+2,105
+7% +$212K 0.03% 507
2019
Q1 		$2.53M Buy
29,197
+10,772
+58% +$917K 0.02% 624
2018
Q4 		$1.16M Sell
18,425
-9,373
-34% -$643K 0.01% 857
2018
Q3 		$2.19M Buy
27,798
+3,339
+14% +$218K 0.02% 657
2018
Q2 		$1.46M Buy
24,459
+9,550
+64% +$514K 0.02% 779
2018
Q1 		$601K Sell
14,909
-463
-3% -$22.6K 0.01% 1243
2017
Q4 		$808K Sell
15,372
-2,221
-13% -$119K 0.01% 1015
2017
Q3 		$829K Buy
17,593
+6,088
+53% +$245K 0.01% 935
2017
Q2 		$407K Buy
11,505
+1,103
+11% +$34K 0.01% 1318
2017
Q1 		$246K Sell
10,402
-105
-1% -$2.08K ﹤0.01% 1503
2016
Q4 		$140K Sell
10,507
-400
-4% -$6.46K ﹤0.01% 1558
2016
Q3 		$203K Buy
+10,907
New +$192K ﹤0.01% 1548
2015
Q3 		– Sell
-7,995
Closed -$238K – 1513
2015
Q2 		$238K Buy
+7,995
New +$201K 0.01% 1177

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Cambridge Investment Research Advisors's EXAS Position: Q1 2026 in Review

Cambridge Investment Research Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 27,703 shares — an estimated $2.81M sold.

Cambridge Investment Research Advisors first reported a position in EXAS in Q2 2015 and held it in 38 quarters. The position peaked at $4.83M in Q4 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Cambridge Investment Research Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 27,703 Exact Sciences shares in Q1 2026, an estimated $2.81M.
  • Cambridge Investment Research Advisors first reported a position in Exact Sciences in Q2 2015 and held it in 38 quarters.
  • Cambridge Investment Research Advisors's Exact Sciences position peaked at $4.83M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.